BRIEF-Whitehawk Therapeutics Advances To Clinical Stage With Ind Clearance For Hwk-007
Reuters
Jan 08
BRIEF-Whitehawk Therapeutics Advances To Clinical Stage With Ind Clearance For Hwk-007
Jan 8 (Reuters) - Whitehawk Therapeutics Inc WHWK.O:
WHITEHAWK THERAPEUTICS ADVANCES TO CLINICAL STAGE WITH IND CLEARANCE FOR HWK-007 AND ANNOUNCES IND SUBMISSION FOR HWK-016
Source text: ID:nPn4LBjW7a
Further company coverage: WHWK.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.